3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Lung Neoplasms
5
Prostatic Neoplasms
2
Breast Neoplasms
2
Stomach Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Paranasal Sinus Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Mesothelioma, Malignant
1
Maxillary Sinus Neoplasms
1
Lymphoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Fasting
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cigarette Smoking-Related Carcinoma
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Appendiceal Neoplasms
1
Interventions
Trastuzumab
2
Interleukin-12 Subunit p35
2
tipifarnib
1
motexafin lutetium
1
entinostat
1
Thalidomide
1
Surveys and Questionnaires
1
Referral and Consultation
1
Quality of Life
1
Psychiatric Rehabilitation
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Irinotecan
1
Interleukin-12
1
Immunotherapy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Fentanyl
1
Erlotinib Hydrochloride
1
Early Intervention, Educational
1
Drug Therapy
1
Docetaxel
1
Counseling
1
Cisplatin
1
Cetuximab
1
Capecitabine
1
Biological Therapy
1
7-hydroxystaurosporine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Appendiceal Neoplasms
×
Referral and Consultation
×
Thoracic
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled